These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
400 related items for PubMed ID: 9678832
1. Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen. Ebner C, Siemann U, Bohle B, Willheim M, Wiedermann U, Schenk S, Klotz F, Ebner H, Kraft D, Scheiner O. Clin Exp Allergy; 1997 Sep; 27(9):1007-15. PubMed ID: 9678832 [Abstract] [Full Text] [Related]
9. Dissection of the grass allergen-specific immune response in patients with allergies and control subjects: T-cell proliferation in patients does not correlate with specific serum IgE and skin reactivity. Würtzen PA, van Neerven RJ, Arnved J, Ipsen H, Sparholt SH. J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):241-9. PubMed ID: 9500758 [Abstract] [Full Text] [Related]
10. IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE. Niederberger V, Laffer S, Fröschl R, Kraft D, Rumpold H, Kapiotis S, Valenta R, Spitzauer S. J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):258-64. PubMed ID: 9500760 [Abstract] [Full Text] [Related]
11. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination. Ball T, Linhart B, Sonneck K, Blatt K, Herrmann H, Valent P, Stoecklinger A, Lupinek C, Thalhamer J, Fedorov AA, Almo SC, Valenta R. Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361 [Abstract] [Full Text] [Related]
12. Grass-specific CD4(+) T-cells exhibit varying degrees of cross-reactivity, implications for allergen-specific immunotherapy. Archila LD, DeLong JH, Wambre E, James EA, Robinson DM, Kwok WW. Clin Exp Allergy; 2014 Jul; 44(7):986-98. PubMed ID: 24708411 [Abstract] [Full Text] [Related]
13. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation. Möbs C, Slotosch C, Löffler H, Jakob T, Hertl M, Pfützner W. J Immunol; 2010 Feb 15; 184(4):2194-203. PubMed ID: 20048125 [Abstract] [Full Text] [Related]
14. Molecular, immunological, and structural characterization of Phl p 6, a major allergen and P-particle-associated protein from Timothy grass (Phleum pratense) pollen. Vrtala S, Fischer S, Grote M, Vangelista L, Pastore A, Sperr WR, Valent P, Reichelt R, Kraft D, Valenta R. J Immunol; 1999 Nov 15; 163(10):5489-96. PubMed ID: 10553075 [Abstract] [Full Text] [Related]
15. Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy. Ball T, Sperr WR, Valent P, Lidholm J, Spitzauer S, Ebner C, Kraft D, Valenta R. Eur J Immunol; 1999 Jun 15; 29(6):2026-36. PubMed ID: 10382766 [Abstract] [Full Text] [Related]
16. A B Cell Epitope Peptide Derived from the Major Grass Pollen Allergen Phl p 1 Boosts Allergen-Specific Secondary Antibody Responses without Allergen-Specific T Cell Help. Narayanan M, Freidl R, Focke-Tejkl M, Baranyi U, Wekerle T, Valenta R, Linhart B. J Immunol; 2017 Feb 15; 198(4):1685-1695. PubMed ID: 28093528 [Abstract] [Full Text] [Related]
17. Cloning, expression and immunological characterization of full-length timothy grass pollen allergen Phl p 4, a berberine bridge enzyme-like protein with homology to celery allergen Api g 5. Dewitt AM, Andersson K, Peltre G, Lidholm J. Clin Exp Allergy; 2006 Jan 15; 36(1):77-86. PubMed ID: 16393269 [Abstract] [Full Text] [Related]
18. B cell epitopes of the major timothy grass pollen allergen, phl p 1, revealed by gene fragmentation as candidates for immunotherapy. Ball T, Fuchs T, Sperr WR, Valent P, Vangelista L, Kraft D, Valenta R. FASEB J; 1999 Aug 15; 13(11):1277-90. PubMed ID: 10428753 [Abstract] [Full Text] [Related]
19. Characterization of Phl p 4, a major timothy grass (Phleum pratense) pollen allergen. Fischer S, Grote M, Fahlbusch B, Müller WD, Kraft D, Valenta R. J Allergy Clin Immunol; 1996 Jul 15; 98(1):189-98. PubMed ID: 8765834 [Abstract] [Full Text] [Related]
20. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis. Rossi RE, Monasterolo G, Coco G, Operti D. Int Arch Allergy Immunol; 2005 Oct 15; 138(2):105-10. PubMed ID: 16174987 [Abstract] [Full Text] [Related] Page: [Next] [New Search]